Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Head and/or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00305734
What this trial is testing

Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Recurrent Nasopharyngeal CancerStage IV Nasopharyngeal Cancer
National Cancer Institute (NCI) 50
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Large-scale testing (Phase 3)UnknownNCT01880359
What this trial is testing

AF CRT +/- Nimorazole in HNSCC

Who this might be right for
Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers
European Organisation for Research and Treatment of Cancer - EORTC 640
Testing effectiveness (Phase 2)Study completedNCT04666688
What this trial is testing

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorPancreatic Cancer+3 more
PureTech 44
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Early research (Phase 1)Study completedNCT03491709
What this trial is testing

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

Who this might be right for
Colorectal Cancer
Dragonboat Biopharmaceutical Company Limited 18
Testing effectiveness (Phase 2)Study completedNCT00939627
What this trial is testing

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT06006169
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 186
Large-scale testing (Phase 3)Study completedNCT01302834
What this trial is testing

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Radiation Therapy Oncology Group 987
Testing effectiveness (Phase 2)Study completedNCT05271604
What this trial is testing

Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and NeckRecurrent Squamous Cell Carcinoma of the Head and Neck+2 more
BioAtla, Inc. 42
Testing effectiveness (Phase 2)Study completedNCT02360501
What this trial is testing

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 50
Large-scale testing (Phase 3)UnknownNCT02465736
What this trial is testing

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerOesophageal Cancer
Sun Yat-sen University 610
Testing effectiveness (Phase 2)Study completedNCT03194373
What this trial is testing

Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Michigan Rogel Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT01855854
What this trial is testing

Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Carcinoma
Betta Pharmaceuticals Co., Ltd. 54
Testing effectiveness (Phase 2)Looking for participantsNCT06781567
What this trial is testing

Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma

Who this might be right for
Adenoid Cystic CarcinomaHead and Neck Cancer
HitGen Inc. 140
Not applicableStudy completedNCT04672772
What this trial is testing

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 531
Testing effectiveness (Phase 2)Active Not RecruitingNCT03813836
What this trial is testing

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
University College, London 63
Testing effectiveness (Phase 2)Study completedNCT00215644
What this trial is testing

Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Merck KGaA, Darmstadt, Germany 72
Early research (Phase 1)Ended earlyNCT02254044
What this trial is testing

Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus

Who this might be right for
Carcinoma, Squamous Cell
Boehringer Ingelheim 7
Not applicableStudy completedNCT02365844
What this trial is testing

Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer

Who this might be right for
Oropharyngeal CarcinomaOropharynx Cancer
Stanford University 81
Next Page